ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Keros Therapeutics Inc

Keros Therapeutics Inc (KROS)

15.92
0.09
(0.57%)
Closed January 02 3:00PM
15.90
-0.02
(-0.13%)
After Hours: 4:11PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0008k143k83k37k388k
Operating Income -31.96M-38.87M-41.34M-43.28M-46.46M-48.48M-50.44M-58.66M
Pre Tax Income -29.72M-35.8M-37.51M-39.44M-40.24M-43.11M-45.26M-52.96M
Net Income -29.72M-35.8M-37.51M-39.44M-40.24M-43.11M-45.26M-52.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -29.72M-35.8M-37.51M-39.44M-55M-48.92M-50.64M-58.75M
EBITDA -31.81M-38.7M-41.15M-43.07M-46.21M-48.21M-50.13M-58.34M
Year End December 30 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 10M10M020.1M0151k
Operating Income -1.69M-10.56M-46.66M-56.37M-114.79M-169.94M
Pre Tax Income -1.08M-12.34M-45.53M-56.73M-104.68M-152.99M
Net Income -1.34M-12.34M-45.36M-58.74M-104.68M-152.99M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.595-5.077-1.956-2.45-3.801-5.107
EBIT -1.08M-12.33M-45.53M-56.73M-104.68M-167.75M
EBITDA -1.54M-10.36M-46.38M-56M-114.09M-169.13M